Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Talis Biomedical (TLIS)
NASDAQ:TLIS
Talis Biomedical (TLIS) Financial Statements
40 Followers
Talis Biomedical Financial Overview
| Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | |
|---|---|---|---|---|---|
| Income Statement | - | ||||
| Total Revenue | $ 140.00K | - | - | $ 257.00K | $ 730.00K |
| Gross Profit | $ 134.00K | $ -7.00K | $ -20.00K | $ -6.89M | $ -506.00K |
| EBIT | $ -15.68M | $ -15.03M | $ -17.83M | $ -26.93M | $ -26.79M |
| EBITDA | $ -15.46M | $ -14.87M | $ -17.66M | $ -23.37M | $ -22.86M |
| Net Income Common Stockholders | $ -15.68M | $ -15.03M | $ -17.83M | $ -26.93M | $ -26.02M |
| Balance Sheet | - | ||||
| Cash, Cash Equivalents and Short-Term Investments | $ 88.00M | $ 99.21M | $ 113.97M | $ 130.19M | $ 143.78M |
| Total Assets | $ 107.23M | $ 123.08M | $ 133.05M | $ 169.29M | $ 194.09M |
| Total Debt | $ 20.08M | $ 20.38M | $ 14.71M | $ 33.58M | $ 33.33M |
| Net Debt | $ -67.91M | $ -78.83M | $ -99.26M | $ -96.61M | $ -110.46M |
| Total Liabilities | $ 25.67M | $ 26.91M | $ 22.93M | $ 42.55M | $ 41.71M |
| Stockholders Equity | $ 81.56M | $ 96.17M | $ 110.12M | $ 126.74M | $ 152.39M |
| Cash Flow | - | ||||
| Free Cash Flow | $ -11.21M | $ -14.76M | $ -16.49M | $ -13.59M | $ -21.68M |
| Operating Cash Flow | $ -11.14M | $ -14.27M | $ -16.46M | $ -13.54M | $ -20.82M |
| Investing Cash Flow | $ -70.00K | $ -485.00K | $ -24.00K | $ -49.00K | $ -860.00K |
| Financing Cash Flow | - | - | $ 33.00K | - | $ 92.00K |
Talis Biomedical Forecast EPS vs Actual EPS
Currently, no data available
Please return soon. This page is being updated.